However, the review summary of the application said,
"The PD and institution have ties to one of the lead clinical trials, which could result in the appearance of a conflict of interest. Reviewers commented that policies should be in place to ensure that the relationships are clearly defined and separated."
“It will make California a go-to place for stem cell therapies. I want to make sure it's part of our medical fabric."